Cookson Peirce & Co’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Cookson Peirce & Co's ADPT Position: Q3 2026 in Review
Cookson Peirce & Co sold out of Adaptive Biotechnologies (ADPT) in Q3 2026, closing a stake of 40,449 shares — an estimated $868K sold.
Cookson Peirce & Co first reported a position in ADPT in Q2 2025 and held it in 3 quarters. The position peaked at $1.72M in Q4 2025. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Cookson Peirce & Co reported no remaining Adaptive Biotechnologies position as of Q3 2026 after selling out during the quarter.
- Cookson Peirce & Co sold 40,449 Adaptive Biotechnologies shares in Q3 2026, an estimated $868K.
- Cookson Peirce & Co first reported a position in Adaptive Biotechnologies in Q2 2025 and held it in 3 quarters.
- Cookson Peirce & Co's Adaptive Biotechnologies position peaked at $1.72M in Q4 2025.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.